N. Alcock

发表

Hormonal and metabolic response to recombinant human tumor necrosis factor in rat: in vitro and in vivo.

S. Calvano, R. Warren, M. Brennan, 1988, The American journal of physiology.

Oxidative stress in the splenotoxicity of aniline.

G. Ansari, P. Boor, M. F. Khan, 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations.

D. Kelsen, C. Young, N. Alcock, 1985, American journal of clinical oncology.

Sepsis-induced cascade of cytokine mRNA expression: correlation with metabolic changes.

H. Starnes, L. Byerley, N. Alcock, 1992, The American journal of physiology.

Iron exacerbates aniline-associated splenic toxicity.

G. Ansari, P. Boor, M. F. Khan, 1999, Journal of toxicology and environmental health. Part A.

Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).

E. Casper, D. Kelsen, C. Young, 1979, Cancer treatment reports.

Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.

E. Casper, J. Lewis, D. Kelsen, 1983, Cancer treatment reports.

Comparison of methods of evaluating nephrotoxicity of cis‐platinum

R. Gralla, M. Schwartz, J. Mládek, 1980, Clinical pharmacology and therapeutics.

Crown ether complexes of BiIII. Synthesis and crystal and molecular structures of BiCl3·12-crown-4 and 2BiCl3·18-crown-6

N. Alcock, G. R. Willey, M. Ravindran, 1989 .

Transition-metal host complexes designed for critical-locus accommodation of organic guest molecules-an approach to a new kind of coordination catalysts patterned after enzymes

K. Takeuchi, D. Busch, N. Alcock, 1983 .

GUEST-HOST ASSOCIATION BY TRANSITION-METAL COMPLEXES CONTAINING PERMANENT VOIDS - PROGRESS TOWARD MODELS FOR THE TERNARY COMPLEX OF CYTOCHROME P450

K. Takeuchi, D. Busch, N. Alcock, 1981 .

Synthesis and structure of antimony(III)chloride-1,4,7,10,13,16-hexaoxocyclooctadecane-(18-crown-6)-acetonitrile (1/1/1)

S. Roe, N. Alcock, G. R. Willey, 1990 .

Pharmacokinetics of cisplatin regional hepatic infusions.

J. Fortner, D. Kelsen, J. Hoffman, 1982, American journal of clinical oncology.

Hematopoietic toxicity of linoleic acid anilide: importance of aniline.

G. Ansari, P. Boor, M. F. Khan, 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[13N]cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors.

S. Strother, D. Rottenberg, V. Dhawan, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The structure of the uranyl triperoxide ion

N. Alcock, 1966 .

Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).

J. Burchenal, H. Scher, B. Leyland-Jones, 1982, Cancer research.

Phase I Clinical Trial and Pharmacokinetics of 4'-Carboxyphthalato-(1,2-diaminocyclohexane)platinum(il)1

J. Burchenal, B. Leyland-Jones, D. Kelsen, 2006 .

Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline.

D. Bajorin, G. Bosl, D. Niedzwiecki, 1986, Cancer research.